2. 您的位置
3. 首页
4. 会议论文
5. The identification and pathological roles of IL-22 in acute graft-versus-host disease following allo

The identification and pathological roles of IL-22 in acute graft-versus-host disease following allo

来源 :中国免疫学会第十届全国免疫学学术大会 | 被引量 : 0次 | 上传用户：wly8213

【摘 要】

：

Aim: To explore the role of IL-22 in GVHD and the properties of IL-22-producing cells.Materials and Methods: GVHD mice model were established and treated with murine IL-22 or PBS respectively.

【作 者】

：

Kai Zhao Lingyu Zeng Kailin Xu 

【机 构】

：

Xuzhou Medical College

【出 处】

：

中国免疫学会第十届全国免疫学学术大会

【发表日期】

：

2015年10期

【关键词】

：

allo-HSCT GVHD IL-22 T cell 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Aim: To explore the role of IL-22 in GVHD and the properties of IL-22-producing cells.Materials and Methods: GVHD mice model were established and treated with murine IL-22 or PBS respectively.

其他文献

The switch from WT1 to Egr-1 binding on TGF-β1 promoter contributes to the committed differentiation

Aims: Early growth response gene l(Egr-1) and The Wilmstumor 1 (WT1) have been implicated in macrophage differentiation induced by phorbol ester (PMA) and the pathogenesis of leukemia respectively.

会议

WT1Egr-1TGF-β1leukemia

Type 1 Regulatory T Cell Differentiation Induced by IL-12 Is Impaired in Patients with Sj(o)gren

Background and Objectives: Type 1 regulatory T cell (Tr1) is an inducible subset of regulatory T cells, characterized by the capability to secrete immunosuppressive cytokine IL-10.

会议

IL-12Sj(o)grens SyndromeTr1 cell

Clinical and serological characteristics of primary Sj(o)gren's syndrome with IgG4-positive pla

Objective: The purpose of this study was to investigate the clinical and serological characteristics of Primary Sjgrens syndrome (pSS) patients with different proportion of IgG4-positve plasma cells i

会议

Primary Sj(o)gren's syndromeIgG4-positve plasma cellsSalivary Gland

Aloperine attenuate mice symptoms from colitis by regulating PI3K/AKT/mTOR signaling pathway and Fox

Aloperine has been recognized with the potential capacity to treat inflammatory and allergic diseases as well as colitis.Treg plays a key role in IBD.

会议

ColitisAloperineTregsPI3K/AKT/mTOR

Bone marrow-derived mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versu

Objective: Bone marrow-derived mesenchymal stem cells (MSCs) could exert a potent immunosuppressive effect, and therefore may have a therapeutic potential in T-cell-dependent pathologies.

会议

AllorejectionCell-based therapyGraft-versus-host diseaseHemopoietic stem cell

Identification of a Novel Biomarker Gene Set With Sensitivity and Specificity for Distinguishing Bet

Objective: Here we examined whether the expression of a novel immunoregulatory gene set could be used to predict outcomes in murine models of rapamycin-induced cardiac tolerance, spontaneous hepatic t

会议

Allograft rejectionAllograft toleranceGene

Eicosapentenoic acid attenuates allograft rejection in an HLA-B27/EGFP transgenic rat cardiac transp

Objective: The development of an animal model bearing definite antigens is important to facilitate the evaluation and modulation of specific allo-antigen responses after transplantation.

会议

AllograftGFPHLA-B27Regulatory T cellToleranceTransgenic rat

Non-myeloablative conditioning is sufficient to induce mixed chimerism and subsequent acceptance of

Objective: Organ transplant recipients have elevated cancer and viral infection risks due to immunosuppression and long-term results of organ transplantation remain unsatisfactory, mainly because of c

会议

AllograftsBusulfanChimerismFTY720Non-myeloablative perioperative regimen

Ischemic preconditioning protects against liver ischemia/ reperfusion injury via heme oxygenase-1-me

Objective: Ischemic preconditioning (IPC) exerts a protective effect in hepatic ischemia/reperfusion (I/R) injury.The exact mechanism of IPC action remains largely unknown.

会议

AutophagyIschemic PreconditioningHepatoprotectionLiver I/R injuryHeme oxygen

肝移植他克莫司最小化应用

背景：肝移植后长期的免疫抑制剂如他克莫司(FK506)的应用会带来许多严重的副作用如感染、肾毒性、代谢紊乱等。肝移植他克莫司最小化应用是最终目标。材料与方法：本研究分为三部分分别对肝移植后短期(4周)、长期(10年以上)受者FK506浓度进行优化，第三部分对FK506剂型进行优化：第一部分：对本中心2009年到2011年235例移植病人进行回顾性分析，根据术后1月内FK506平均浓度及变异程度(S

会议

肝移植他克莫司排斥